Location History:
- South San Francisco, CA (US) (2022)
- San Francisco, CA (US) (2021 - 2023)
Company Filing History:
3 out of 846 
2 out of 262 
Years Active: 2021-2023
Title: Innovator Spotlight: Ai Ling Ching
Introduction: Ai Ling Ching is a prominent inventor based in San Francisco, California, renowned for his contributions to the pharmaceutical industry. With a total of five patents to his name, his work exhibits a keen focus on drug formulation and inventive medical solutions.
Latest Patents: Among his most recent innovations, Ai Ling Ching has developed a formulation for a pan-JAK inhibitor. This patent addresses pharmaceutical compositions that include a specific compound, along with methods of use and preparation. Additionally, he has created a patent for lisinopril compositions that involve ingestible event markers, showcasing a combination of lisinopril with silicon and other substances, alongside innovative apparatuses and methods for utilizing these compositions.
Career Highlights: Throughout his career, Ai Ling Ching has worked with leading organizations in the pharmaceutical sector, such as Otsuka Pharmaceutical Company, Limited and Theravance Biopharma R&D IP, LLC. His expertise and innovations have significantly contributed to advancements in medication formulations and technologies.
Collaborations: Ai Ling Ching has collaborated with notable colleagues, including Kurt Scheinpflug and Nikhil Pargaonkar. These partnerships have fostered an environment of innovation and teamwork, leading to successful patent applications and contributions to the field.
Conclusion: Ai Ling Ching continues to be a driving force in pharmaceutical innovations, with a track record of successful patents. His work not only enhances the effectiveness of existing medications but also paves the way for future advancements in health care solutions.